Polyphosphoinositides suppress the adhesion of Haemophilus influenzae to pharyngeal cells

Lipids in Health and Disease

Volumn 3, Issue , 2004, Pages

  Liu, Jim Wen R ^a   Anderson, Steve N ^a   Meulbroek, Jonathan A ^a   Hwang, Shie Ming ^a   Mukerji, Pradip ^a   Huang, Yung Sheng ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 QUINOLINOL INDIUM IN 111; DIPALMITOYLPHOSPHATIDYLINOSITOL 3,4 DIPHOSPHATE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL 3 PHOSPHATE; PHOSPHATIDYLINOSITOL 4 PHOSPHATE; POLYPHOSPHOINOSITIDE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; BACTERIAL CELL; CELL ADHESION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN CELL; ISOTOPE LABELING; NASOPHARYNX; NONHUMAN; PHARYNX; PHARYNX CARCINOMA; RAT; TEMPERATURE MEASUREMENT;

BACTERIA (MICROORGANISMS); HAEMOPHILUS; HAEMOPHILUS INFLUENZAE;

EID: 5444244365     PISSN: 1476511X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-511X-3-20     Document Type: Article

References (15)

1. Pelton S: Prevention of acute and recurrent otitis media. Lancet 2000, 356:1370-1371.
2. Uhari M, Kontiokari T, Koskela M, Niemela M: Xylitol chewing gum in prevention of acute otitis media: double blind randomized trial. BMJ 1996, 313:1180-1184.
3. Kontiokari T, Uhari M, Koskela M: Antiadhesive effects of xylitol on otopathogenic bacteria. J Antimicrob Chemother 1998, 41:563-565.
4. Zopf D, Roth S: Oligosaccharide anti-infective agents. Lancet 1996, 347:1017-1021.
5. Ukkonen P, Varis K, Jernfors M, Herva E, Jokinen J, Ruokokoski E, Zopf D, Kilpi T: Treatment of acute otitis media with an antiadhesive oligosaccharide: a randomised, double-blind, placebo-controlled trial. Lancet 2000, 356:1398-1402.
6. Aniansson G, Andersson B, Lindstedt R, Svanborg C: Anti-adhesive activity of human casein against Streptococcus pneumoniae and Haemophilus influenzae. Microb Pathog 1990, 8:315-323.
7. Mukerji P, Hwang SM, Huang YS, Liu JW, Anderson SN, Meulbroek J: Bioactive rice flour extract useful for treatment of Haemophilus influenzae infection. US Patent 2001. No. 6,248,372
8. Janoff AS, Alving CR, Fountain MW, Lenk RP, Ostro MJ, Popescu MC, Tremblay PA, Weiner AL: Drug preparations of reduced toxicity. US Patent 1990. No. 4,897,384-900130
9. Lodhi S, Weiner ND, Mechigian I, Schacht J: Ototoxicity of aminoglycosides correlated with their action on monomolecular films of polyphosphoinositides. Biochem Pharmacol 1980, 29:597-601.
10. Di Massimo C, Mascioli A, Amicosante G, Tozzi-Ciancarelli MG: Interaction of neomycin with human erythrocytes. Cell Mol Biol (Noisy-le-grand) 1993, 39:383-387.
11. Wang PY, Kitchens RL, Munford RS: Phosphatidylinositides bind to plasma membrane CD14 and can prevent monocyte activation by bacterial lipopolysaccharide. J Biol Chem 1998, 273:24309-24313.
12. Swords WE, Buscher BA, Steeg KV, Preston A, Nichols WA, Weiser JN, Gibson BW, Apicella MA: Non-typeable Haemophilus influenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor. Mol Microbiol 2000, 37:13-27.
13. Swords WE, Ketterer MR, Shao J, Campbell CA, Weiser JN, Apicella MA: Binding of the non-typeable Haemophilus influenzae lipooligosaccharide to the PAF receptor initiate host cell signalling. Cell Microbiol 2001, 3:525-536.
14. Weiser JN: Relationship between colony morphology and the life cycle of Haemophilus influenzae : The contribution of lipopolysaccharide phase variation to pathogenesis. J Infect Dis 1993, 168:672-680.
15. Weiser JN, Austrian R, Sreenivasan PK, Masure HR: Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect Immun 1994, 62:2582-2589.